Oragenics Inc logo

Oragenics Inc

AMEX:OGEN (USA)  
$ 1.53 -0.09 (-5.56%) 07:08 PM EST
At Loss
P/B:
6.65
Volume:
15.92K
Avg Vol (2M):
129.40K
Trade In:
Volume:
15.92K
At Loss
Avg Vol (2M):
129.40K

Business Description

Description
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.
Name Current Vs Industry Vs History
Cash-To-Debt 16.32
Equity-to-Asset 0.74
Debt-to-Equity 0.05
Debt-to-EBITDA -0.01
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 17.05
9-Day RSI 32.75
14-Day RSI 41.05
6-1 Month Momentum % -56.37
12-1 Month Momentum % -20.75

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.69
Quick Ratio 2.69
Cash Ratio 2.28

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -26.3
Shareholder Yield % -21.73
Name Current Vs Industry Vs History
ROE % -340.07
ROA % -273.87
ROIC % -1561.28
ROC (Joel Greenblatt) % -1710.18
ROCE % -337.57

GF Value Rank

Name Current Vs Industry Vs History
PB Ratio 6.65
Price-to-Tangible-Book 6.65
EV-to-EBIT -0.34
EV-to-EBITDA -0.34
EV-to-FCF -0.84
Price-to-Net-Cash 5.88
Earnings Yield (Greenblatt) % -294.12
FCF Yield % -120.29

Financials (Next Earnings Date:2024-08-09 Est.)

OGEN's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with AMEX:OGEN

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Oragenics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -8.54
Beta 1.37
Volatility % 144.46
14-Day RSI 41.05
14-Day ATR ($) 0.226265
20-Day SMA ($) 1.9578
12-1 Month Momentum % -20.75
52-Week Range ($) 1 - 7.74
Shares Outstanding (Mil) 4.48

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Oragenics Inc Filings

Filing Date Document Date Form
No Filing Data

Oragenics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Oragenics Inc Frequently Asked Questions

What is Oragenics Inc(OGEN)'s stock price today?
The current price of OGEN is $1.53. The 52 week high of OGEN is $7.74 and 52 week low is $1.00.
When is next earnings date of Oragenics Inc(OGEN)?
The next earnings date of Oragenics Inc(OGEN) is 2024-08-09 Est..
Does Oragenics Inc(OGEN) pay dividends? If so, how much?
Oragenics Inc(OGEN) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1